• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

The Dawn of the Intelligence Age: How AI is Transforming Science and Medicine

user avatar

by Giorgi Kostiuk

2 years ago


On September 23, Sam Altman, co-founder and CEO of OpenAI, released an essay declaring the arrival of the “Intelligence Age.” Altman claims that AI will lead to exponential advancements including climate solutions and discoveries in physics. Despite criticism, AI is already being utilized in various scientific fields and medicine, accelerating research and improving healthcare services.

Artificial Intelligence in Ultrasound Imaging

GE Verisound AI employs proprietary software to assist non-experts in capturing high-quality ultrasound images of the heart, aiding in earlier disease detection. One of the company's main offerings, Caption AI, provides real-time visual guidance and quality measurement to ensure high-resolution images. The AutoEF feature, driven by AI algorithms, calculates critical heart health metrics such as the left ventricular ejection fraction.

AI in Drug Discovery

San Francisco-based Atomwise uses AI to accelerate the drug discovery process. Their AtomNet platform utilizes convolutional neural networks to predict the efficacy of potential drug candidates before costly clinical trials. By analyzing experimental affinity measurements and protein structures, AtomNet speeds up the identification of safe and effective drug candidates, significantly reducing the time and cost of bringing new medicines to market. In April 2024, Atomwise successfully identified novel drug candidates for 235 out of 318 targets.

The Role of AI in Radiology

Behold.ai is developing AI-assisted radiology with its “red dot” algorithm, which classifies chest X-rays and localizes findings as heat maps using deep learning models. The algorithm achieves 90% accuracy in detecting abnormalities within seconds, reducing radiologists' workloads and diagnosis wait times. Similarly, Enlitic uses deep learning to interpret medical images, enabling the detection of malignant lung nodules up to 18 months before a biopsy.

AI is playing a significant role in scientific research and medical advancements. Its applications, from ultrasound imaging to drug discovery and medical image interpretation, highlight its tremendous potential to improve healthcare and accelerate scientific progress.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

WLFI Token Price Declines Amidst Controversy

chest

The price of World Liberty Financial (WLFI) tokens has significantly declined, dropping below $0.008 and losing over 20% of its value due to growing controversies surrounding the project.

user avatarKofi Adjeman

World Liberty Financial Faces Liquidity Concerns

chest

World Liberty Financial (WLFI) is facing scrutiny due to its financial practices, having deposited nearly $2 billion in tokens into the Dolomite lending protocol and borrowed over $31 million in stablecoins, raising liquidity concerns.

user avatarNguyen Van Long

Justin Sun Accuses World Liberty Financial of Deception

chest

Justin Sun accuses World Liberty Financial of having a backdoor in its smart contract, allowing the team to freeze user funds without warning.

user avatarSatoshi Nakamura

Brian Armstrong Supports Clarity Act Amid Legislative Push

chest

Brian Armstrong, CEO of Coinbase, publicly supports the Digital Asset Market Clarity Act of 2025, urging Congress to pass it.

user avatarJesper Sørensen

HYPE Token Experiences Major Price Surge Amid Market Trends

chest

HYPE token has surged over 65% year-to-date and nearly 200% over the past year, reflecting strong market performance amid uncertainties.

user avatarLucas Weissmann

Bitwise Moves Closer to Launching Spot Hyperliquid ETF

chest

Bitwise has filed a second amendment with the SEC for its spot Hyperliquid ETF, adding new trading counterparties ahead of its launch.

user avatarRajesh Kumar

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.